Global Intravenous (IV) Iron Drugs Market: 2011 Edition
Topics: Blood Diseases, Pharmaceuticals, Needles, Syringes, IV Access
Regions: Global
|
Hemophilia Global Clinical Trials Review, H2, 2011
Topics: Blood Diseases, Drug Discovery
|
Future Technology Trends and Upcoming Players in Hemophilia Therapeutics Market
Topics: Blood Diseases
|
Chemotherapy Induced Anemia - Pipeline Review, H2 2011
Topics: Blood Diseases
|
Hemophilia A Global Clinical Trials Review, H2, 2011
Topics: Blood Diseases, Clinical Trial
|
Hemophilia - Pipeline Review, H2 2011
Topics: Blood Diseases, Drug Discovery
|
Hemophilia B - Pipeline Review, H2 2011
Topics: Blood Diseases, Drug Discovery
|
Anemia - Pipeline Review, H2 2011
Topics: Blood Diseases
|
Hemophilia A - Pipeline Review, H2 2011
Topics: Blood Diseases, Drug Discovery
|
Blood, Organ & Ambulatory Health Services in the US - Industry Risk Rating Report
Topics: Blood Diseases, Services
Regions: United States
|
Bleeding and Clotting Disorders Global Clinical Trials Review, H2, 2011
Topics: Blood Diseases, Drug Discovery, Clinical Trial
|
Blood Disorders Therapeutics Market to 2017 - Patent Expiries of Lovenox, Plavix, Procrit/Epogen, Aranesp and Neulasta Will Slow Down Growth
Topics: Blood Diseases
|
Coagulation Disorders Market to 2017 - Hemophilia A, the Largest Segment, to Witness a Decline in Growth Rate due to Patent Expiries and Weak Pipeline
Topics: Blood Diseases, Coagulation
|
Hemophilia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Blood Diseases
|
Special Report: Do Emerging Therapies Offer Better Treatment Options for Hemophilia Patients?
Topics: Blood Diseases
|
Iron Deficiency Anemia - Pipeline Review, H2 2011
Topics: Blood Diseases
|
Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Topics: Blood Diseases, Drug Discovery
|
Hemophilia B Global Clinical Trials Review, H2, 2011
Topics: Blood Diseases, Drug Discovery
|
Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemia in Chronic Kidney Disease in the US
Topics: Blood Diseases, Research & Development, Oncology/Hematology
Regions: United States
|
Hemophilia Global Clinical Trials Review, Q1, 2011
Topics: Blood Diseases, Clinical Trial
|
Hemophilia A Global Clinical Trials Review, Q1, 2011
Topics: Blood Diseases, Clinical Trial
|
Hemophilia B Global Clinical Trials Review, Q1, 2011
Topics: Blood Diseases, Drug Discovery, Clinical Trial
|
Iron Deficiency Anemia - Pipeline Review, Q2 2011
Topics: Blood Diseases, Dietary Supplements, Drug Discovery
|
Chemotherapy Induced Anemia - Pipeline Review, Q1 2011
Topics: Blood Diseases
|
Myelodysplastic Syndrome Therapy Area Pipeline Report
Topics: Blood Diseases
|
Thrombocytopenia and Idiopathic Thrombocytopenic Purpura Therapy Area Pipeline Report
Topics: Blood Diseases
|
Hemophilia - Pipeline Review, Q1 2011
Topics: Blood Diseases, Drug Discovery
|
Anemia Therapy Area Pipeline Report
Topics: Blood Diseases
|
Haemophilia and Blood Coagulation Disorders Therapy Area Pipeline Report
Topics: Blood Diseases
|
Hemorrhage Therapy Area Pipeline Report
Topics: Blood Diseases
|
Hemophilia A - Pipeline Review, Q1 2011
Topics: Blood Diseases, Drug Discovery
|
Anemia Global Clinical Trials Review, Q1, 2011
Topics: Blood Diseases, Drug Discovery
|
Anemia Therapy Pipeline Report
Topics: Blood Diseases, Drug Discovery
|
Haemophilia and Blood Coagulation Disorders Therapy Pipeline Report
Topics: Blood Diseases, Drug Discovery
|
Hemophilia - Pipeline Assessment and Market Forecasts to 2017
Topics: Blood Diseases
|
Iron Deficiency Anemia - Pipeline Review, Q4 2010
Topics: Blood Diseases
|
Anemia - Pipeline Review, Q4 2010
Topics: Blood Diseases
|
Hemophilia - Pipeline Review, Q4 2010
Topics: Blood Diseases
|
Hemophilia A - Pipeline Review, Q4 2010
Topics: Blood Diseases, Drug Discovery
|
Hemophilia B - Pipeline Review, Q4 2010
Topics: Blood Diseases, Drug Discovery
|
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Topics: Blood Diseases, Coagulation, Cardiovascular
|
Anemia - Pipeline Assessment and Market Forecasts to 2017
Topics: Blood Diseases, Research & Development
|
Anticoagulants
Topics: Blood Diseases, Cardiovascular
Regions: Global
|
Intravenous (IV) Iron Drugs
Topics: Blood Diseases, Needles, Syringes, IV Access
|
Stakeholder Opinions: Hemophilia - The harsh reality of commercialising a great research opportunity?
Topics: Blood Diseases, Drug Discovery
|
Pipeline Insight: Lymphomas, Multiple Myeloma & Myelodysplastic Syndromes - Optimization of clinical practice creates opportunities for emerging therapies
Topics: Stem Cell, Blood Diseases, Research & Development, Drug Discovery, Oncology/Hematology
|
Anemia Drugs
Topics: Blood Diseases, Research & Development, Prescription Drugs, Drug Discovery
|
The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities
Topics: Blood Diseases
|
Myelodysplastic Syndromes (High-Risk)
Topics: Biomarkers, Blood Diseases, Drug Delivery, Drug Discovery
|
Blood and Lymphatic System Dyslipidemia Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery, Cardiovascular
|
